Novo Nordisk Kills Off Oral Insulin Project

Many in the Type 1 diabetes community wish for two things: lower insulin prices and non-injectable insulin. Now, there’s evidence that the former may have killed off the latter. According to a Fierce Biotech report, Novo Nordisk announced in an October 31st earnings call that it is halting research and development efforts aimed at creating an oral form of insulin.

Read more

Posted in Glucose & Insulin